tumors news from FierceBiotech
News
Avant shares soar on positive cancer vaccine data
On the same day that Ted Kennedy was undergoing brain surgery to remove a tumor, Read more...
Biotechs merge to form Aduro BioTech
Berkeley, CA-based Oncologic has merged with Triton BioSystems into a new developer named Aduro BioTech. The combined biotech will focus on developing iron oxide nanoparticles to attack solid tumors. Read more...
SPOTLIGHT: $1B program catalogs cancer triggers
An international consortium of researchers has launched a billion-dollar effort to map every way that changes in DNA contributes to the development of tumors. The newly launched International Cancer Read more...
SGX shares slide on report of early-stage toxicity
Shares of SGX Pharmaceuticals were sliding this morning on the news that its lead cancer therapy Read more...
Pfizer snaps up Serenex in buyout
Pfizer has beefed up its prospects in the cancer arena with today's buyout of Durham, NC-based Serenex. The biotech Read more...
Novocell reports breakthrough in diabetes cure
Researchers at Novocell report a key breakthrough in their program to find a cure for Read more...
Mixed data from two Threshold cancer trials
California-based Threshold Pharmaceuticals has released an update on its glufosfamide program. According to the company's release, a Phase II trial of the drug for soft tissue sarcoma "provided Read more...
Idera shares surge on Merck KGaA pact
Idera is pocketing a $40 million up front fee from Merck KGaA and hopes to make an additional $381 Read more...
Delcath shares hammered on trial enrollment suspension
Shares of Delcath Systems went into free fall this morning, losing about two thirds of their value after the company announced that regulators from the FDA asked researchers to temporarily suspend Read more...
Introgen reports biomarker link to new therapy
Introgen Therapeutics says that their researchers have found a statistically significant link between an abnormal p53 biomarker and response to their experimental therapy for head and neck cancer. Read more...
Get more tumors coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets